Model Checkpoint Epoch: 2.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 32
	QLoRA Alpha: 48.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is associated with an increased risk of neonatal morbidity. Neonatal morbidity is also associated with birth weight percentile. Therefore, BF% could be a better measure of undernutrition than birth weight percentile. However, it may not be possible to replace birth weight as the most commonly used measure of fetal growth restriction and prematurity in clinical practice. Further studies are needed to confirm our findings. In addition, these data highlight the importance of monitoring BF% in high-risk populations such as those born small for gestational age or in those who have preterm birth. This may help identify infants at high risk of morbidity and improve strategies for prevention and management of undernutrition.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.6
Reasoning:
The assistant's reply is broadly correct: it notes that low BF% is associated with higher neonatal morbidity and concludes BF% could be a better marker than birth weight percentiles, which matches the study findings. However, the answer omits important nuances from the ground truth (that BF% can identify neonates who are appropriately grown by weight yet undernourished and can exclude small neonates not at risk), and it includes an incorrect or unsupported suggestion about using BF% in preterm infants even though the study only included term neonates. It also could have cited the relative strengths of association (ORs) to support the claim. 

conciseness: 0.8
Reasoning:
The assistant's reply directly answers the question — it states BF% could be a better measure and briefly explains why — and keeps to a few sentences. It includes useful caveats (practical limitations, need for further study) but does not quote the study's comparative effect sizes or prevalence numbers, which would make it slightly more informative without adding much length. Overall the response is clear and to the point with only minor room for tightening.

relevance: 0.8
Reasoning:
The assistant's reply is generally relevant and addresses the question: it correctly states that low BF% is more strongly associated with neonatal morbidity than birth weight percentiles and concludes BF% could be a better measure. It paraphrases findings from the context and appropriately hedges (notes need for further study and that BF% may not replace birth weight in practice). However, it makes one inappropriate extrapolation by recommending monitoring BF% in preterm infants even though the study population was term neonates; it also does not quote any exact text from the context. Overall the response answers the question and reflects the study findings but includes a minor, incorrect extension beyond the study population.

coherence: 0.7
Reasoning:
The response is concise and follows a logical structure: it states the main finding (low BF% linked to higher morbidity), acknowledges that birth weight percentiles are also associated, draws a tentative conclusion that BF% could be a better measure, and notes practical limitations and need for further study. It is coherent and communicates uncertainty appropriately. Minor weaknesses in coherence: it omits quantitative detail (effect sizes, prevalence) that would strengthen the comparison, uses vague phrasing ("may not be possible to replace") without justification, and inappropriately suggests monitoring BF% in preterm infants despite the study being limited to term neonates.

helpfulness: 0.6
Reasoning:
The assistant's reply correctly concludes that low BF% is associated with higher neonatal morbidity and that BF% could be a better marker than birth weight percentiles. It is concise and appropriately cautious about clinical implementation and the need for further study. However, it omits key quantitative evidence from the study (the larger effect size for BF% vs birth weight percentiles), does not mention that BF% can identify appropriately grown yet undernourished infants (and exclude some small infants who are not at risk), and is a bit vague about study limitations and generalizability. Overall the answer is moderately helpful but could be improved by citing the comparative odds ratios and explicitly stating how BF% adds diagnostic value.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The ischemic Charcot neuroarthropathy is considered as a severe complication of peripheral artery disease and may have a poor prognosis. Although it has been suggested that ischemic Charcot neuroarthropathy should be treated with an early surgical intervention, no consensus exists regarding the optimal treatment strategy. Our results confirm that early surgery is effective in achieving limb salvage. However, further studies are needed to define the best approach to treat this condition. Our study suggests that the combination of endovascular revascularization, surgical debridement and orthopedic correction can be considered as a good option in treating this condition.
In addition, the use of an early surgical intervention should be combined with aggressive wound management, including antibiotic therapy, debridement and offloading, to improve the outcome. A better understanding of the pathophysiology and natural history of ischemic Charcot neuroarthropathy is necessary to develop more effective treatment strategies.
Our preliminary findings suggest that the use of endovascular revascularization should be considered only when there is clear evidence of ischemia on MRI, but further studies are needed to confirm these results. This will allow us to determine whether endovascular revascularization is appropriate for all patients or only those with specific clinical signs and symptoms.
Another important issue is the role of orthopedic correction. We found that the combination of surgical and orthopedic correction is safe and effective in restoring blood flow and preventing further neurological damage. Further studies are needed to compare the results obtained with different types of orthopedic procedures.
Finally, we also observed that the duration of the surgical procedure and the length of hospital stay were significantly shorter than previously reported. This finding may reflect a change in surgical technique and postoperative management.
In conclusion, the results of our study support the concept of a multidisciplinary approach to the treatment of ischemic Charcot neuroarthropathy. Early diagnosis and treatment should focus on preserving limb function, reducing pain and improving quality of life. Further studies are needed to validate our results and to establish the standard treatment protocols for ischemic Charcot neuroarthropathy.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.4
Reasoning:
Short explanation:
The response correctly emphasizes a multidisciplinary approach and that endovascular revascularization combined with surgical/orthopedic treatment can achieve high limb-salvage rates — which matches the study's main finding. However, it includes several inaccurate or unsupported statements (for example, implying MRI is the primary evidence for ischemia, and that orthopedic correction "restores blood flow"), and it makes some unreferenced generalizations (shorter procedure/hospital stay) and ambiguous recommendations (when exactly to revascularize). Overall the answer partially matches the ground truth but contains clinically incorrect or unsupported claims that could mislead.

conciseness: 0.3
Reasoning:
The response is verbose and repetitive and does not concisely answer the user's question. It wanders into speculative recommendations and unsupported specifics (e.g., MRI criterion) instead of directly stating whether ischemic Charcot foot represents a different clinical entity and summarizing the key, concise result of the study (that combined endovascular revascularization plus surgical/orthopedic treatment led to limb salvage in 90% with mean healing time ~197 days). For conciseness alone, this answer is below average.

relevance: 0.4
Reasoning:
The response is only partially relevant. It does address the question by recommending a multidisciplinary approach and highlights combined endovascular revascularization plus surgical/orthopedic treatment, which matches the study context (limb salvage after combined treatment). However, it also introduces unsupported or incorrect assertions not present in the provided context (for example, that revascularization should be limited to MRI-proven ischemia, that orthopedic correction "restores blood flow," and that procedure/hospital stay were shorter), and it fails to cite the actual results reported (90% limb salvage, mean healing time ~197 days). These unsupported additions reduce the answer's fidelity to the given context.

coherence: 0.6
Reasoning:
The response is generally organized and addresses the question by asserting that ischemic Charcot neuroarthropathy requires a multidisciplinary approach (including revascularization, surgery and orthopedic management) and that early intervention can aid limb salvage. It is coherent in structure (intro, findings, recommendations, conclusion). However, it contains a few unclear or internally inconsistent points (e.g., recommending endovascular revascularization only when ischemia is evident on MRI, and claiming orthopedic correction “restores blood flow”), some unsupported generalizations, and some repetition. Overall it communicates a plausible, structured answer but includes problematic specifics and lapses in precision.

helpfulness: 0.4
Reasoning:
Brief explanation:
The assistant's reply is broadly aligned with the notion that ischemic Charcot foot benefits from a multidisciplinary approach and combined revascularization, surgical debridement and orthopedic treatment, but it is weak in precision, sourcing, and relevance to the specific question. It fails to state the concrete study findings (90% limb salvage, mean healing time ≈197 days) and does not clearly answer whether ischemic Charcot foot is a distinct entity requiring different treatment. The reply also makes several problematic or unsupported statements (e.g., recommending MRI as the primary evidence of ischemia, claiming orthopedic correction “restores blood flow,” and asserting shorter operative/hospital times without data). Overall the answer is somewhat helpful in reiterating that combined therapy is reasonable, but it is imprecise, occasionally inaccurate, and lacks key study results and clear comparison of treatment strategies.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: The type of hysterectomy does not influence survival in patients with endometrial cancer with suspected gross cervical involvement. This finding should be reassuring to physicians when making treatment decisions. The type of surgery is an important factor in patient selection, but its impact on survival is minimal. Radical hysterectomy may be unnecessary in some cases and could result in morbidity without improving survival. Further studies should focus on developing new methods of diagnosis and treatment. Patients with suspected gross cervical involvement should be selected based on tumor size, grade, and other clinical parameters. Future research should also investigate the role of adjuvant therapy after radical hysterectomy.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.8
Reasoning:
The assistant's answer is largely correct: it states the study's main finding that the type of hysterectomy (radical vs modified radical vs simple) did not affect survival and that radical hysterectomy can cause additional morbidity without improving outcomes. It also appropriately calls for further research. However, the reply is a bit vague and omits several important study details (the specific prognostic factors identified — age, grade, peritoneal cytology, lymph node involvement — and the specific increased perioperative/late adverse events seen with RH such as longer operative time, higher transfusion rates, and more urinary dysfunction). It also generalizes recommendations (e.g., selecting patients by tumor size) beyond what the study specifically tested. Overall accurate but incomplete and slightly imprecise.

conciseness: 0.6
Reasoning:
The assistant conveys the main conclusion (type of hysterectomy does not affect survival and radical hysterectomy may add morbidity) but is somewhat repetitive and adds extra, nonessential recommendations (e.g., broader future research topics) that reduce conciseness. It also omits specific adverse-event details that were in the study summary. Overall clear but not as succinct as it could be.

relevance: 0.6
Reasoning:
Explanation: The assistant's reply is relevant and correctly conveys the study's primary conclusion — that radical hysterectomy (RH) did not improve survival and may increase morbidity — which matches the provided context. It is concise and answers the question directly. However, it omits specific data from the report (no mention of the identified prognostic factors such as age, grade, peritoneal cytology, and lymph node involvement), does not cite a direct quote or precise findings (e.g., longer operative time, higher transfusion rates, urinary dysfunction in RH), and adds some recommendations (selecting patients by tumor size; studying adjuvant therapy) that go beyond the data presented. Overall the response is accurate in its main point but somewhat incomplete and slightly speculative in its recommendations.

coherence: 0.7
Reasoning:
The assistant's reply is overall coherent and summarizes the main conclusion of the GOTIC study — that radical hysterectomy does not improve survival and may add morbidity. It is concise and reasonably organized, but somewhat vague: it omits specific adverse-event findings (longer operative time, higher transfusion rates, urinary dysfunction) and includes a mild contradiction by calling type of surgery “an important factor in patient selection” while also saying its impact on survival is minimal. It also suggests future research directions without explicitly recommending prospective trials as in the ground truth.

helpfulness: 0.7
Reasoning:
The assistant's response correctly conveys the study's main conclusion that type of hysterectomy (including radical hysterectomy) did not improve survival for endometrial cancer with suspected gross cervical involvement and that radical hysterectomy is associated with increased morbidity. It therefore answers the question helpfully and succinctly. However, it omits several study details that would strengthen the summary (that multivariate analysis did not select hysterectomy type as an independent prognostic factor for local recurrence-free survival, PFS, or OS; the specific adverse outcomes observed such as longer operative time, higher transfusion rates, and urinary dysfunction; and that the data come from a retrospective multicenter series), and it offers some vague or slightly speculative recommendations (e.g., “developing new methods of diagnosis”) rather than concrete implications (need for prospective evaluation). Overall, accurate and useful but somewhat incomplete and non-specific.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD are associated with poor prognosis and increased health care expenditures. The current literature suggests that readmissions may be related to pancreatic fistula, multivisceral resection, length of initial hospital stay>7 days, ICU admissions, and biochemical variables such as elevated creatinine levels. Therefore, it is important to focus on the prevention of readmissions. Our findings suggest that readmissions occur mostly within 7 days from initial operative discharge. The reasons for immediate and nonimmediate readmissions are different and should be taken into consideration when developing strategies to prevent readmissions. Future studies should focus on the development of evidence-based guidelines to prevent readmissions. Prevention strategies should include early identification of patients at high risk for readmissions, close follow up, and prompt interventions based on the etiology of readmissions. In addition, our findings support the need for future studies evaluating the cost-effectiveness of these interventions. Early identification of patients at high risk of readmission would allow us to target our efforts and resources more effectively. To improve patient outcomes and reduce costs, further evaluation is necessary. Moreover, early intervention based on preoperative assessment of patients' comorbidities could lead to improved patient outcomes. Future studies should also focus on identifying the most effective timing and method for providing postoperative instructions and support. Finally, our results highlight the importance of an early interdisciplinary team approach to addressing readmissions. This approach may help identify potential issues earlier and ensure that appropriate interventions are implemented in a timely manner. Furthermore, this approach will help facilitate communication among providers, which is critical for ensuring optimal patient outcomes.
(1) Patients should receive detailed written instructions prior to discharge regarding the management of postoperative complications. These instructions should include information about the signs and symptoms of pancreatic fistula and other possible complications and how to seek medical attention if they develop. (2) The use of standardized postoperative protocols including specific criteria for reoperation, may help minimize the likelihood of unnecessary readmissions. (3) Providers should consider using a system to track patients' progress after discharge by telephone or home visits. (4) Further studies are needed to evaluate whether the application of specific readmission reduction strategies in the context of PD leads to better outcomes. (5) Future studies should investigate the impact of specific interventions on readmission rates in patients undergoing PD. (6) Patient education should be enhanced through the use of multimedia educational materials such as videos and interactive programs to increase awareness of readmission risks and their prevention. (7) Future studies should examine the effect of hospital readmission rates on patient satisfaction, quality of life, and long-term survival after PD. (8) Evaluation of the impact of readmission reduction strategies on patient quality of life and functional status is warranted. (9) Future studies should explore the role of the role of the surgeon's experience in reducing readmission rates after PD. (10) The use of hospital readmission rates as a quality indicator should be considered to promote a culture of readmission reduction. (11) Further studies should examine the impact of readmission reduction strategies on the costs of health care services. (12) Patient education should be enhanced through the use of multimedia

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.6
Reasoning:
The response correctly identifies the main independent predictors of readmission after PD reported in the study (pancreatic fistula and complex/multivisceral resection) and highlights that many readmissions occur early (within 7 days) and therefore merit targeted prevention efforts. It sensibly recommends practical prevention strategies (early identification of high‑risk patients, close follow-up, patient education, standardized protocols, and interdisciplinary care). However, it contains a factual error — it states that postoperative biochemical variables such as elevated creatinine are associated with readmissions, whereas the study explicitly found no postoperative biochemical predictors. The answer is also somewhat repetitive and vague about specific, evidence-based interventions for preventing early readmissions.

conciseness: 0.3
Reasoning:
Explanation: The assistant's reply is verbose and repetitive, listing many generic future-study recommendations and duplicated items rather than giving a concise, prioritized answer. It does mention relevant risk factors (pancreatic fistula, complex resection, early readmissions) but adds unnecessary repetitions and some inconsistent statements (e.g., referencing biochemical predictors despite no such predictors reported). Overall it fails to be succinct or focused on the most actionable prevention points.

relevance: 0.6
Reasoning:
The assistant's answer is generally relevant: it responds to the question by summarizing risk factors and suggesting prevention strategies, and it notes that many readmissions occur within 7 days and that early and late readmission causes differ (which aligns with the context). However, it incorrectly asserts that postoperative biochemical variables (e.g., elevated creatinine) are associated with readmissions despite the context stating no postoperative biochemical predictors, and the recommendations are somewhat generic and repetitive rather than tightly focused on preventing early readmissions. Overall partially accurate and relevant but with notable errors and verbosity.

coherence: 0.6
Reasoning:
The response is generally coherent and organized: it summarizes key risk factors (pancreatic fistula, complex/multivisceral resections, prolonged initial stay, ICU admission), highlights that many readmissions occur early (≤7 days), and lists practical prevention strategies (patient education, close follow-up, standardized protocols, interdisciplinary care). However it is repetitive, contains some inaccuracies relative to the provided data (it incorrectly implies postoperative biochemical variables such as creatinine are predictive when the ground truth states no biochemical predictors were found), and ends abruptly/redundantly. Overall the structure is acceptable but the content could be tighter and more accurate.

helpfulness: 0.6
Reasoning:
The response gives a generally useful, practical set of prevention strategies (early identification of high‑risk patients, close follow‑up, patient education, standardized protocols, interdisciplinary care) and notes that readmissions often occur early and for different reasons — points that are relevant and actionable. However, it contains at least one incorrect statement (it claims postoperative biochemical variables such as elevated creatinine are predictive, whereas the ground truth states no postoperative biochemical variables were predictive), is somewhat repetitive and unfocused with many generic calls for future study, and does not clearly prioritize preventing early (≤7‑day) readmissions despite noting their frequency. Overall helpful but flawed in accuracy and concision.

================================================================================
Average correctness Score: 0.515
Average conciseness Score: 0.485
Average relevance Score: 0.545
Average coherence Score: 0.58
Average helpfulness Score: 0.49
